beta-carboxyaspartic acid has been researched along with dihydralazine in 1 studies
| Studies (beta-carboxyaspartic acid) | Trials (beta-carboxyaspartic acid) | Recent Studies (post-2010) (beta-carboxyaspartic acid) | Studies (dihydralazine) | Trials (dihydralazine) | Recent Studies (post-2010) (dihydralazine) |
|---|---|---|---|---|---|
| 5 | 0 | 0 | 416 | 62 | 18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barlocco, D; Cignarella, G; Germini, M; Loriga, M; Pinna, GA; Sala, F; Tofanetti, O | 1 |
1 other study(ies) available for beta-carboxyaspartic acid and dihydralazine
| Article | Year |
|---|---|
Conformationally restricted congeners of hypotensive and platelet aggregation inhibitors: 6-aryl-5-methyl-4,5-dihydro-3(2H)-pyridazinones derived from 5H-indeno[1,2-c]pyridazine.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Fibrinolytic Agents; Guinea Pigs; In Vitro Techniques; Male; Mice; Platelet Aggregation; Pyridazines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1986 |